MULTICENTRIC OBSERVATIONAL RETROSPECTIVE STUDY ON BACTERIAL / FUNGAL / VIRAL INFECTIONS IN PATIENTS WITH SECONDARY ACUTE MYELOID LEUKEMIA TREATED WITH DAURORUBICIN-CITARABINE LIPOSOMIAL (VYXEOS) IN THE “REAL-LIFE” 22 Novembre 2020
MULTICENTRIC RETROSPECTIVE STUDY OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES TREATED WITH TARGET THERAPY – SEIFEM STUDY 2017 (AN UPGRATED) 22 Novembre 2020
EPIDEMIOLOGY OF COVID-19 INFECTION IN PATIENTS WITHHEMATOLOGICAL MALIGNANCIES: A EUROPEAN HAEMATOLOGY ASSOCIATION SURVEY 22 Novembre 2020
SEIFEM OBSERVATIONAL PROSPECTIVE STUDY ON INFECTIOUS COMPLICATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) TREATED WITH DEMETHYLATING AGENTS 20 Gennaio 2020
PROSPECTIVE, OBSERVATIONAL, MULTICENTER STUDY OF THE ROLE OF PRIMARY ANTIFUNGAL PROPHYLAXIS TO PREVENT INVASIVE ASPERGILLOSIS IN ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA UNDERGOING CONSOLIDATION THERAPY. 29 Gennaio 2019
REVISION OF ANTIFUNGAL STRATEGIES DEFINITIONS FOR INVASIVE FUNGAL INFECTIONS (PROVEN/PROBABLE/POSSIBLE) IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES (REDIFI-SEIFEM). 29 Gennaio 2019
INFECTION CAUSED BY GEOTRICHUM IN PATIENTS AFFECTED WITH HEMATOLOGICAL MALIGNANCIES. AN INTERNATIONAL MULTICENTER STUDY 22 Marzo 2018
